Not available
Quote | Medidata Solutions Inc. (NASDAQ:MDSO)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $92.22 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/03/2019 04:46:52 pm |
News | Medidata Solutions Inc. (NASDAQ:MDSO)
Randy Rasmussen, the Chief Accounting Officer of Phreesia, Inc. (NYSE:PHR) is set to become the company’s new Chief Financial Officer with effect from May 1, 2021, as the current CFO, Tom Altier, retires.Altier, who joined Phreesia in 2012, “played a critical role in the success...
Message Board Posts | Medidata Solutions Inc. (NASDAQ:MDSO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $MDSO News Article - Medidata Merger Investigation: Halper Sadeh LLP Announces Investig | whytestocks | investorshangout | 06/12/2019 1:10:42 PM |
whytestocks: $MDSO News Article - Dassault Syst mes and Medidata Solutions To Join Forces To Acceler | whytestocks | investorshangout | 06/12/2019 12:30:41 PM |
whytestocks: $MDSO News Article - Medidata to Present Breakthrough Innovation at 2019 ASCO Annual Me | whytestocks | investorshangout | 05/24/2019 4:05:40 PM |
whytestocks: $MDSO News Article - Medidata Announces First Quarter 2019 Earnings Conference Call | whytestocks | investorshangout | 04/16/2019 12:35:41 PM |
MDSO bullish 56.21 | stocktrademan | investorshub | 09/22/2016 1:50:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Medidata Solutions Inc. Company Name:
MDSO Stock Symbol:
NASDAQ Market:
Medidata Solutions Inc. Website:
Study Site Analytics, available through iMedidata.com, helps sites manage performance with a dashboard providing consistent, standardized metrics across sites Dashboard includes metrics for enrollment, screen failure, and early termination, with anonymized benchmark comparisons to o...
Company Celebrates 20 Years of Innovation Under Tarek Sherif’s Leadership; Transforming Drug Development and Clinical Trial Technology Medidata celebrates 20 years of innovation as the Operating System for Life Sciences Company dedicates success to the support an...
Life Science Executives Agree that Precision Medicine Represents a New Era in Drug Development , According to the Newsweek Vantage and Medidata Survey Report Investment in IT systems is one of the top three barriers to precision medicine Unified data strategies...